Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Dec 21, 2023; 29(47): 6111-6121
Published online Dec 21, 2023. doi: 10.3748/wjg.v29.i47.6111
Figure 3
Figure 3 Differences between fecal calprotectin and Ulcerative Colitis Colonic Index of Severity in terms of predicting relapse and the receiver-operating characteristic analysis for predicting relapse. A: Difference in fecal calprotectin (FC) levels between the relapse and remission groups; B: Difference in Ulcerative Colitis Colonic Index of Severity (UCCIS) between the relapse and remission groups; C: Receiver-operating characteristic analysis of FC and UCCIS for predicting relapse within 1 year. aP < 0.001. FC: Fecal calprotectin; UCCIS: Ulcerative colitis colonic index of severity.